S 1806
104th Congress
Senate
Health
Agriculture and Food
Commerce
Dietary supplements
Drug abuse
Drugs
Labeling
Psychotropic drugs
A bill to amend the Federal Food, drug, and Cosmetic Act to clarify that any dietary supplement that claims to produce euphoria, heightened awareness or similar mental or psychological effects shall…
Show full title
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 23, 1996
Read twice and referred to the Committee on Labor and Human Resources.
May 23, 1996
Sponsor introductory remarks on measure. (CR S5582-5583)
May 23, 1996
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Amends the Federal Food, Drug, and Cosmetic Act to consider a dietary supplement a drug if its labeling claims or implies that the supplement produces euphoria, heightened awareness, or similar mental or psychological effects.
What's happening now
Read twice and referred to the Committee on Labor and Human Resources.
Bill text
1 version
- Introduced in Senate Formatted Text PDF
Committees of jurisdiction
1
Cosponsors
1
Cite this page
U.S. Congress. (2026). S. 1806: A bill to amend the Federal Food, drug, and Cosmetic Act to clarify that any dietary supplement that claims to produce euphoria, heightened awareness or similar mental or psychological effects shall be treated as a drug under the Act, and for other purposes.. 104th Congress. Open America. https://openamerica.io/bill/104-S-1806/
"S. 1806: A bill to amend the Federal Food, drug, and Cosmetic Act to clarify that any dietary supplement that claims to produce euphoria, heightened awareness or similar mental or psychological effects shall be treated as a drug under the Act, and for other purposes.." 104th Congress, 2026, Open America, https://openamerica.io/bill/104-S-1806/.
S. 1806, 104th Cong. (2026), https://openamerica.io/bill/104-S-1806/.
[S. 1806: A bill to amend the Federal Food, drug, and Cosmetic Act to clarify that any dietary supplement that claims to produce euphoria, heightened awareness or similar mental or psychological effects shall be treated as a drug under the Act, and for other purposes.](https://openamerica.io/bill/104-S-1806/)